These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9097712)

  • 21. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
    Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
    J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of AgNORS in fine needle aspiration cytology of breast lesions.
    Rajeevan K; Aravindan KP; Kumari BC
    Indian J Pathol Microbiol; 1995 Jan; 38(1):17-24. PubMed ID: 8919465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleolar organizer regions (AgNOR) and subepithelial vascularization as field cancerization markers in oral mucosa biopsies of alcoholic and smoking patients.
    López-Blanc SA; Collet AM; Gandolfo MS; Femopase F; Hernández SL; Tomasi VH; Paparella ML; Itoiz ME
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Nov; 108(5):747-53. PubMed ID: 19748291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleolar organizer regions in superficial spreading melanoma with nodule.
    Albrecht S; Jambrosic JA; Kahn HJ
    Mod Pathol; 1989 Nov; 2(6):666-70. PubMed ID: 2587571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AgNOR quantification with special reference to staining patterns.
    Rüschoff J; Fauser G; Knüchel R; Hofstädter F
    Zentralbl Pathol; 1994 Mar; 140(1):23-30. PubMed ID: 7515669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool.
    Giuffrè G; Mormandi F; Barresi V; Bordi C; Tuccari G; Barresi G
    Eur J Histochem; 2006; 50(1):45-50. PubMed ID: 16584984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wet autoclave pretreatment improves the visualization of silver-stained nucleolar organizer-region-associated proteins in routinely formalin-fixed and paraffin-embedded tissues.
    Ofner D; Bankfalvi A; Riehemann K; Bier B; Böcker W; Schmid KW
    Mod Pathol; 1994 Dec; 7(9):946-50. PubMed ID: 7892164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes?
    Giuffrè G; Barresi G; Speciale G; Sarnelli R; Gioffrè Florio MA; Tuccari G
    Eur J Histochem; 1997; 41(2):111-8. PubMed ID: 9271703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstration of the nucleolar organizer region by silver staining (AgNOR method) in research and in histopathological practice.
    Kodousek R; Dusek J
    Acta Univ Palacki Olomuc Fac Med; 1991; 131():9-37. PubMed ID: 1726500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleolar organizer regions (NORs) in the cells of normal mucosa and tumors of human colon.
    Zaczek M; Nowakowa K; Szoł W; Chłap Z
    Patol Pol; 1991; 42(2):63-7. PubMed ID: 1845397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The study of AgNOR proteins in leukemias: diagnostic value and correlation to S-phase cell fraction.
    Klobusická M; Babusíková O; Mesárosová A; Kusenda J; Glasová M
    Neoplasma; 1996; 43(6):397-401. PubMed ID: 8996564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modified silver staining of nucleolar organizer regions to improve the accuracy of image analysis.
    Orrea SC; Tomasi VH; Schwint AE; Itoiz ME
    Biotech Histochem; 2001 Mar; 76(2):67-73. PubMed ID: 11440307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of nucleolar organizer regions in the histopathological diagnosis of colorectal epithelial neoplasia.
    Chida T; Ajioka Y; Watanabe H
    Jpn J Clin Oncol; 1992 Apr; 22(2):73-8. PubMed ID: 1377759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AgNOR and breast cancer. A study by image analysis.
    Ronco A; Larran J; López A; Vilches J
    Histol Histopathol; 1994 Apr; 9(2):309-13. PubMed ID: 8075491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative evaluation of AgNORs in bone tumours.
    Arora B; Jindal K; Kumar S; Rekhi B; Arora H; Arora DR
    Pathology; 2003 Apr; 35(2):106-8. PubMed ID: 12745456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interphase AgNOR quantity and DNA content in endometrial adenocarcinoma.
    Trerè D; Melchiorri C; Chieco P; Marabini A; Derenzini M
    Gynecol Oncol; 1994 May; 53(2):202-7. PubMed ID: 8188080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Argyrophil organizer region proteins (AgNORs) in adenohypophysial cells and adenomas of the human pituitary.
    Stefaneanu L; Horvath E; Kovacs K
    Mod Pathol; 1989 May; 2(3):192-9. PubMed ID: 2474815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of AgNOR counts and morphometric analysis of nuclear parameters in premalignant and malignant lesions of the uterine cervix.
    Wierzchniewska A; Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 1998; 49(4):297-301. PubMed ID: 10323085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.